Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × UNKNOWN × Trastuzumab × Clear all

Phase

Status

Unknown 3 Completed 1

Sponsor Class

OTHER 177 INDUSTRY 154 NIH 34 NETWORK 21 OTHER_GOV 3 UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1

Interventions

S 1 (combination) 6 Cisplatin 6 Radiotherapy, Intensity-Modulated 5 Paclitaxel 4 Oxaliplatin 3 Irinotecan 3 titanium silicide 2 raltitrexed 2 nimotuzumab 2 Radiotherapy 2 Radiation Dose Hypofractionation 2 Capecitabine 2 pegylated granulocyte colony-stimulating factor 1 icaritin 1 anlotinib 1 Trastuzumab 1 TP protocol 1 Surgical Procedures, Operative 1 Radiotherapy, Adjuvant 1 Radiation 1 Pharmaceutical Preparations 1 Ondansetron 1 Methylene Blue 1 Lidocaine 1 Injections 1 Indocyanine Green 1 Gemcitabine 1 Fluorouracil 1 Etoposide 1 Erlotinib Hydrochloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02725424 2022-08-17

MATCH

ChineseAMS

Phase 2 Completed

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡